Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Eli Lilly & Co. Q3 2008 Earnings Conference Call Transcript
- Question-and-Answer SessionAbsolutely. [Operator Instructions]. And your first question is from the line of Tony Butler, Barclays Capital. Please go ahead. Anthony Butler - Barclays Capital Thanks very much. John, it would appear that Gemzar or Strattera and Evista may have actually peaked in sales, and I am curious if...
- Earnings calls 2008-10-23
- NMT Medical, Inc. Q1 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. Our first question comes from the line of Jonathan Block with SunTrust Robinson Humphrey. Please proceed with your question, your mic is now live. Jonathan Block - SunTrust Robinson Humphrey Hey. Just first on VSD, we model U.S. sales of...
- Earnings calls 2009-05-06
- BNET Focus on Antidepressants: Part 3, the Future
- The future for branded antidepressants as a business looks grim. Here's the current patent expiration schedule for the four biggest sellers: GlaxoSmithKline's Paxil CR expires in 2008 Wyeth's Effexor XR expires in 2011 Forest Labs' Lexapro expires in 2012 Eli Lilly's Cymbalta expires in...
- Blog posts 2008-10-02
Additional Resources
- Using a Simulation Model to Incorporate the Cost of Catastrophe Excess Reinsurance Into the Property Rate Level Indication Using the Net Cost of Reinsurance Method or How I Learned to Stop Worrying and Love the Net Cost of Reinsurance Method
- Although much has been written on how to properly determine reinsurance premium, relatively little literature exists on how a primary insurer, once it pays that premium, should incorporate the cost of reinsurance into its rate level indication. This paper discusses two approaches for including the cost of catastrophe excess reinsurance...
- White papers 2005-07-29
- ORLISTAT.(Roche wants to add indication for glycemic control)(Brief Article)
- The FDA will review Roche's application to add a new indication to its prescription weight loss drug Xenical orlistat for the ... The FDA will review Roche's application to add a new indication to its prescription weight loss drug Xenical orlistat for the...
- Research articles 2001-05-28
- Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment; Thousands of Additional Patients Now Eligible to Receive Cardiac Resynchronization Therapy Defibrillators
- INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced that the U.S. Food and Drug Administration FDA has approved an expanded indication for the company's portfolio of cardiac resynchronization therapy defibrillators (CRT-D). The expanded indication makes Guidant's cardiac resynchronization therapy defibrillators available to thousands more heart failure patients,...
- Research articles 2004-09-15
- Medtronic Announces European Commission Approval of New Indication for InductOs for Spinal Surgery
- MEMPHIS, Tenn. -- Medtronic Inc. (NYSE:MDT) today announced that the European Commission has approved a spinal fusion indication for InductOsTM, the surgically implanted product containing recombinant human bone morphogenetic protein (rhBMP-2) that promotes new bone growth, or bone regeneration. With the new indication, InductOs is now available for use with...
- Research articles 2005-04-19
- Mobile Content Shows its Softer Side.(wireless CTIA IT show here last week is any indication, mobile technology is literally going soft)
- By Karen Brown Wireless Business Moves to Higher Service Focus Los Angeles-- If the wireless CTIA IT show here last week is any indication, mobile technology is literally going soft -- but that isn't a bad...
- Research articles 2006-09-18
- NORWAY: CENTRE PARTY GIVES CLEAR INDICATION.(Brief Article)
- The Centre Party has given a clear indication that it will support proposals to change the rules applying to the additional cash benefit for children between the ages of one and three, so that only ... The Centre Party has given a clear indication that it will...
- Research articles 2001-02-19
- The European Commission has given a clear indication of its determination to keep its industrial options open on supplying future energy needs.
- Summary: The European Commission has given a clear indication of its determination to keep its industrial options open on supplying future energy needs. In a still-unpublished answer to a series of questions from MEP Alexander Falconer, who calls into Summary: The European Commission has given a clear...
- Research articles 1995-04-07
- Lynch Interactive Announces Withdrawal of Indication of Interest to Purchase Conestoga
- Business Editors RYE, N.Y.--BUSINESS WIRE--Dec. 27, 2001 Lynch Interactive Corporation (ASE:LIC) announced today that it has withdrawn its indication of interest to acquire Conestoga Enterprises, Inc. On December 17, 2001, Conestoga stated that it would not pursue Lynch Interactive's indication of interest to acquire Conestoga for $33...
- Research articles 1970-01-01
- The Role of Confounding by Indication in Assessing the Effect of Quality of Care on Disease Outcomes in General Practice: Results of a Case-Control Study
- In quality of care research, limited information is found on the relationship between quality of care and disease outcomes. This case-control study was conducted with the aim to assess the effect of guideline adherence for stroke prevention on the occurrence of stroke in general practice. It in detail reports on...
- White papers 2005-01-27
- FDA clears new indication for DuPont Merck's Coumadin; 1st anticoagulant to reduce long-term mortality for heart attack survivors
- WILMINGTON, Del.--HealthWire--June 14, 1995--The U.S. Food and Drug Administration FDA has cleared for marketing DuPont Merck's CoumadinR Warfarin Sodium for a new indication -- the treatment of patients who have had a heart attack (myocardial infarction, or MI) to reduce the risk of death, a subsequent MI, and thromboembolic events,...
- Research articles 1995-06-14
- Amgen's NEUPOGEN Filgrastim approved for new use in cost-saving cell transplant procedure for cancer treatment; fourth indication shortens hospitalization and patient time at risk
- THOUSAND OAKS, Calif.--BUSINESS WIRE--Dec. 28, 1995--Amgen (NASDAQ:AMGN) today announced that NEUPOGEN R Filgrastim, the company's recombinant granulocyte colony-stimulating factor, has been approved for its fourth indication and the third received in 18 months. The Food and Drug Administration FDA has cleared the use of NEUPOGEN to support peripheral blood...
- Research articles 1995-12-28
- Xoma starts Neuprex™ efficacy trial for deadly pediatric disease; unveils multi-indication clinical efficacy program
- BERKELEY, Calif.--BUSINESS WIRE--May 11, 1995--XOMA Corporation (NASDAQ:XOMA) today announced the initiation of an efficacy trial of its NeuprexTM (rBPI-21) product for treatment of meningococcemia, a severe bacterial infection which results in massive endotoxin poisoning. This potentially deadly condition generally afflicts children. The study is the first of three...
- Research articles 1995-05-11
- ITC finds 'indication' Korean DRAM prices hurt U.S. semicon industry - Semicon trade issues pending - US International Trade Commission, dynamic random access memories
- BOISE, IDA. -- The International Trade Commission last week ruled there is a "reasonable indication" that pricing on Korean DRAM imports is materially injuring the U.S. semiconductor industry, a decision that gives preliminary validation to a dumping complaint filed in April (EN, April 27) by Micron Technology. The ruling passed...
- Research articles 1992-06-08
- Regulatory Filings Submitted to FDA for a Pediatric Indication and an Intravenous Formulation of Epilepsy Drug Keppra(R) (levetiracetam)
- UCB Pharma, Inc., today announced that it filed a supplemental new drug application sNDA with the U.S. Food and Drug Administration FDA for a pediatric indication for the oral dosage forms of its antiepileptic drug Keppra® levetiracetam, as well as a new drug application NDA for an intravenous form of...
- Research articles 2004-12-22
- OMRIX Biopharmaceuticals Receives FDA Approval for Second Generation Fibrin Sealant, Evicel™, For Use in Liver Surgery; Submits Evicel Phase III Study to FDA for Expanded Indication in Peripheral Vascular Surgery
- NEW YORK -- - Company Advances Expanded General Hemostasis Surgery Indication and Leadership Position in Surgical Hemostasis Market -
- Research articles 2006-07-10
- Safeway Pleased with Early Indication that Southern California Contract Ratified
- PLEASANTON, Calif. -- Safeway Inc. (NYSE:SWY) today said it is pleased at the early indication that the new 2007-2011 Southern California Retail Food and Meat Agreement was ratified this evening by its Southern California Vons and Pavilions employees represented by UFCW Locals 135, 324, 770, 1036, 1167, 1428 and 1442....
- Research articles 2007-07-23
- Comverse Launches Presence Server; Provides A Real-Time Indication Of Users' Availability And Willingness To Communicate For SMS, Mobile IM, And Voice Applications
- NEW YORK -- Comverse, a unit of Comverse Technology, Inc. (NASDAQ: CMVT), and the world's leading supplier of software and systems enabling network-based multimedia enhanced communication services, today announced availability of the Comverse Presence Server. Providing real-time indication of the desired party's ability and willingness to communicate, presence enables operators...
- Research articles 2005-02-07
- << Previous
- page 1 of 1
- Next >>
